PURA Announces 48% YTD Sales Growth And CBD Consumer Products Expansion Plan
August 21 2020 - 9:55AM
InvestorsHub Cannabis NewsWire
Dallas, TX -- August 21, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced a scheduled earnings update to be
published next week on Tuesday, August 25, 2020. In addition
to reviewing the company’s year to date (YTD) performance after
publishing its Q2 2020 financial report, the update will include
new information on the company’s ongoing acquisition campaign to
expand its CBD infused consumer product reach. The update will also
include the latest on the issuance of a dividend distribution to
PURA shareholders resulting from the recent declaration of a stock
dividend in conjunction with the sale of PURA’s cannabis
cultivation operation to PAO Group, Inc. (USOTC:
PAOG).
PURA reported $1.6 million in sales year
to date through Q2 2020. The company reported just shy of
$1.1 million for the same period last year. PURA’s sales
growth YTD compared to the same period last year is 48%.
Management highlights the company’s ongoing sales strength
driven by COVID-19 resilient demand for its EVERx CBD Sports
Water.
For more
information on Puration, visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Sep 2024 to Oct 2024
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Oct 2023 to Oct 2024